Fabrizio Zucca

Director Market Access DACH at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Fabrizio Zucca's Colleagues at Alnylam Pharmaceuticals
Philip Davey

Country Manager (VP), UK & Ireland

Contact Philip Davey

Stefano Calderone

Disease Awareness Specialist

Contact Stefano Calderone

Silvia Torchio

Product Lead PH1 - Europe, Canada, MEA

Contact Silvia Torchio

Ida Sparano

Area Sales Manager North Italy

Contact Ida Sparano

Luisa Asero

Associate Director, Medical Science Liaison

Contact Luisa Asero

Federica Gusson

Associate Director Medical Affair Manager ATTR Amyloidosis

Contact Federica Gusson

Davide Blanco

Associate Director, Key Account & Regional Access Manager

Contact Davide Blanco

View All Fabrizio Zucca's Colleagues
Fabrizio Zucca's Contact Details
HQ
(617) 551-8200
Location
Bonn,North Rhine-Westphalia,Germany
Company
Alnylam Pharmaceuticals
Fabrizio Zucca's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Fabrizio Zucca
Fabrizio Zucca currently works for Alnylam Pharmaceuticals.
Fabrizio Zucca's role at Alnylam Pharmaceuticals is Director Market Access DACH.
Fabrizio Zucca's email address is ***@alnylam.com. To view Fabrizio Zucca's full email address, please signup to ConnectPlex.
Fabrizio Zucca works in the SaaS industry.
Fabrizio Zucca's colleagues at Alnylam Pharmaceuticals are Philip Davey, Stefano Calderone, Silvia Torchio, Ida Sparano, Luisa Asero, Federica Gusson, Davide Blanco and others.
Fabrizio Zucca's phone number is (617) 551-8200
See more information about Fabrizio Zucca